Head-to-head · WeighScore
Revel RX vs Velvet Rx
The verdict
Revel RX takes it — 77.3/100 to 58.1/100.
Revel RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Revel RX is a Michigan-based telehealth weight-loss platform offering compounded semaglutide at $89/month and compounded tirzepatide at $155/month — flat-rate at every dose tier.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Revel RX | Velvet Rx |
|---|---|---|
| WeighScore | 77.3/100 | 58.1/100 |
| Grade | C+ | C |
| Scorecard rank | #47 | #381 |
| Semaglutide | $89/mo (all doses, compounded) | $299/mo (compounded) |
| Tirzepatide | $155/mo (all doses, compounded) | $359/mo (compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #47 · C+
Strengths
- Industry-low flat pricing: $89/mo for compounded semaglutide and $155/mo for tirzepatide at every dose
- LegitScript verified and BBB accredited with an A+ rating — above-average trust signals for a compounded platform
- Named pharmacy partners: Manifest Pharmacy and Red Rock Home Pharmacy (503A + 503B facilities)
- Free overnight cold shipping included; no hidden fees or dose-based price increases
- Clinical review by MD Integrations, an independent medical group, before any prescription is issued
Where it loses points
- States served are not publicly listed; eligible states requires completing intake to confirm coverage
- No labs, coaching, or ongoing health support disclosed in any public materials
- Compounded medications are not FDA-approved (site discloses this)
- Newer brand with limited public patient reviews or Trustpilot rating
- Pharmacy partners named but no accreditation details (PCAB, 503B cGMP) published on the site
Graded #381 · C
Strengths
- Public pricing across 3 SKUs (semaglutide $299, tirzepatide $359, oral GLP-1 $349) — uncommon in compounded telehealth
- First-month promo pricing shown upfront ($139 sema / $199 tirz / $189 oral)
- Single monthly price includes consult, prescription, 4 weeks of medication, and free 1–2 day shipping
- FSA/HSA eligible
- Three options under one roof: injectable sema, injectable tirz, and an oral GLP-1
Where it loses points
- Oral GLP-1 SKU doesn't name the specific drug — a real gap given Rybelsus, Foundayo, and compounded oral semaglutide differ clinically
- No LegitScript or NABP .pharmacy seal displayed
- No legal entity name disclosed
- No physical address disclosed
- Compounding pharmacy partner not named
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.